Express Scripts Says Customers Support Removal Of Several Pfizer Products From Formulary
This article was originally published in The Pink Sheet Daily
Executive Summary
Decision to drop Lipitor and Norvasc from its 2006 formulary represents an opportunity for savings without compromising health outcomes, the PBM says.